Skip to main content
Chemoinformatics Market Analysis North America, Europe, APAC, Middle East and Africa, South America - US, China, Germany, UK, France - Size and Forecast 2024-2028

Chemoinformatics Market Analysis North America, Europe, APAC, Middle East and Africa, South America - US, China, Germany, UK, France - Size and Forecast 2024-2028

Published: Jul 2024 144 Pages SKU: IRTNTR74070

Market Overview at a Glance

$4.57 B
Market Opportunity
13.63%
CAGR
12.14
YoY growth 2023-2024(%)

Chemoinformatics Market Size 2024-2028

The chemoinformatics market size is forecast to increase by USD 4.57 billion at a CAGR of 13.63% between 2023 and 2028.

  • The market is experiencing significant growth due to several key trends. One major factor driving market expansion is the increasing approvals of new molecules and biosimilars In the pharmaceutical industry. This growth is attributed to the advancements in chemoinformatics technologies, which enable faster and more accurate drug discovery and development. Additionally, the extensive adoption of cloud technology in pharmaceutical manufacturing and testing is another significant trend, as it offers cost savings, increased efficiency, and enhanced data accessibility. However, concerns related to data safety remain a challenge for the market, as the use of large databases and complex algorithms necessitates robust security measures to protect sensitive information.
  • Overall, the market is poised for continued growth as it plays a crucial role in accelerating drug discovery and development while addressing the evolving needs of the pharmaceutical industry.

    • What will be the Size of the Chemoinformatics Market During the Forecast Period?

    Chemoinformatics Market Size

     Request Free Sample

  • The market encompasses the application of computational methods from computer science, information science, and chemistry to manage and analyze molecular data for drug discovery and materials science. This market is experiencing significant growth due to the increasing demand for efficient and cost-effective methods In the discovery and development of new drugs and materials. Computational techniques, including machine learning, chemical graph theory, and molecular simulations, are utilized to predict molecular structures, reactions, and interactions. Drug repurposing, a process of discovering new uses for existing drugs, is also gaining traction In the market. Additionally, the integration of healthcare cloud computing and data management solutions enables pharmaceutical firms to streamline their drug screening processes and manage vast amounts of data related to drug candidates.
  • The market is further propelled by the potential for combinatorial chemical methods to generate large libraries of compounds for screening and the increasing focus on addressing complex diseases such as Alzheimer's disease.

    • How is this Chemoinformatics Industry segmented and which is the largest segment?

    The chemoinformatics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    • Application
      • Chemical analysis
      • Drug discovery and validation
      • Virtual screening
      • Others
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • UK
        • France
      • APAC
        • China
      • Middle East and Africa
        • South America

        By Application Insights

        • The chemical analysis segment is estimated to witness significant growth during the forecast period.

        The market experienced significant growth in 2023, with chemical analysis as the largest segment. The expansion was driven by increasing R&D expenditures In the healthcare sector, estimated at USD140-150 billion annually, and the comparatively low success rate of drug molecule leads. The pharmaceutical sector in countries like the US, Japan, Canada, and India saw growth due to the high prevalence of chronic diseases. In addition, the biotechnology industry's focus on drug discovery, material science applications, and computational chemistry fueled market growth. Machine learning techniques, molecular design, and predictive modeling were key areas of investment, with applications in drug discovery, rare diseases, and agrochemical research.

        The chemoinformatics industry provided software solutions for drug design, lead targets, and data mining, while consultancy and training services ensured interoperability and standardized formats. Precision farming and sustainable agrochemical development were also significant areas of application. The market's growth was further boosted by the integration of artificial intelligence, user-friendly interfaces, and healthcare cloud computing. The chemoinformatics industry catered to pharmaceutical and biotechnology companies, academic institutes, and research institutes, with a focus on intellectual property management and personalized medicine. The market's future direction included the development of 3D structures, drug manufacturing, and healthcare services.

        Chemoinformatics Market Size

        Get a glance at the  Chemoinformatics Industry report of share of various segments Request Free Sample

        The Chemical analysis segment was valued at USD 1.4 billion in 2018 and showed a gradual increase during the forecast period.

        Regional Analysis

        • North America is estimated to contribute 32% to the growth of the global market during the forecast period.

        Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

        Chemoinformatics Market Share by Geography

        For more insights on the market share of various regions, Request Free Sample

        The market experienced significant growth in North America due to advancements in healthcare infrastructure, increased funding for research and development, and technological innovations In the US and Canada. The region is home to numerous software providers offering advanced, cloud-based solutions for managing chemical data, such as LifeSphere Intake and Triage, and LifeSphere MultiVigilance by Altoris. These companies prioritize affordability and cutting-edge technology, contributing to the market's expansion. Furthermore, the pharmaceutical industry in North America has seen several product recalls, necessitating the adoption of chemoinformatics tools for improved drug discovery, safety, and regulatory compliance. Key applications include drug discovery, materials science, computational methods, drug repurposing, and machine learning for rare diseases, genomic and proteomic research, agrochemical research, and precision farming.

        The market's growth is driven by the biotechnology sector, pharmaceutical firms, and academic institutes, with a focus on interoperability, standardized formats, and data integration. Additionally, artificial intelligence, user-friendly interfaces, consultancy, training, chemical analysis, molecular modeling, predictive modeling, and computational chemistry applications are integral to the industry. The chemoinformatics industry encompasses drug design, lead targets, big data analytics, data mining, and statistical analysis, with a focus on structure-activity relationship modeling, 3D structure development, and drug manufacturing sector integration. The market's future lies in healthcare services, pharmaceuticals, and sustainable agrochemical development, with continued advancements in computer technology, cloud computing, and precision healthcare.

        Market Dynamics

        Our  researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

        What are the key market drivers leading to the rise In the adoption of Chemoinformatics Industry?

        Increasing approvals of new molecules and biosimilars is the key driver of the market.

      • The market is experiencing significant growth due to the increasing demand for computational methods in drug discovery and materials science. In the biotechnology sector, chemoinformatics is used for target identification, validation, and design, while In the pharmaceutical industry, it is employed for drug screening, virtual screening, molecular dynamics simulations, and predictive modeling. Machine learning techniques, such as regression analysis and support vector machines, are utilized for molecular design, molecular descriptors, and 2D fingerprints. In the healthcare sector, chemoinformatics is applied to personalized medicine and precision healthcare, while In the agriculture sector, it is used for agrochemical research and sustainable agrochemical development.
      • The importance of interoperability, standardized formats, protocols, and data integration is crucial for the effective implementation of chemoinformatics in various industries. Artificial intelligence and user-friendly interfaces are becoming increasingly important in chemoinformatics, enabling faster and more accurate analysis of molecular structures, reactions, and interactions. Chemoinformatics is also used In the development of software solutions for drug validation, pharmaceutical products, and healthcare services. The chemoinformatics industry is driven by the need for new drugs and drug candidates, as well as the growing demand for combinatorial chemical methods and data management in pharmaceutical firms. Chemical graph theory, chemical expansion, and molecular design are some of the key areas of focus In the chemoinformatics industry.
      • The market dynamics of chemoinformatics are influenced by various factors, including the high cost of drug discovery and development, the need for compliance with safety standards, and the increasing importance of big data analytics, data mining, and statistical analysis in drug discovery and development. The use of visualization features and computer technology, including cloud computing, is also transforming the chemoinformatics industry. In conclusion, the market is a dynamic and evolving industry that plays a crucial role in drug discovery, materials science, and various other applications. Its importance is underscored by the high stakes involved in drug development and the need for effective and efficient methods for analyzing molecular structures, reactions, and interactions.
      • The use of computational techniques, machine learning, and artificial intelligence is transforming the chemoinformatics industry, enabling faster and more accurate analysis and design of molecules, and contributing to the development of new drugs and pharmaceutical products.

        • What are the market trends shaping the Chemoinformatics Industry?

        Extensive adoption of cloud technology in pharmaceutical manufacturing and testing is the upcoming market trend.

      • The market is experiencing significant growth due to the increasing adoption of computational methods in various sectors, including drug discovery, materials science, and agrochemical research. The use of machine learning, artificial intelligence, and other advanced technologies is revolutionizing the way we design new drugs, identify targets, and develop molecular models. Open-source platforms are also gaining popularity, providing access to standardized formats, protocols, and data integration tools. In the biotechnology sector, pharmaceutical firms and research institutes are leveraging chemoinformatics for drug discovery and development, target identification and validation, and personalized medicine. Similarly, In the agriculture sector, precision farming and sustainable agrochemical development are driving the demand for computational chemistry applications.
      • The chemoinformatics industry is also witnessing the integration of genomics, proteomics, and other omics data, enabling more accurate and predictive modeling. The use of 2D fingerprints, topological indices, and molecular descriptors is facilitating structure-activity relationship modeling and ML algorithms such as regression analysis and support vector machines. Moreover, the availability of user-friendly interfaces, consultancy, and training services is making these technologies accessible to a wider audience. The pharmaceutical manufacturing sector and healthcare services are also benefiting from these advancements, with the pharmaceuticals industry and healthcare cloud computing playing a crucial role in drug screening, virtual screening, and molecular dynamics simulations.
      • Despite the numerous benefits, challenges such as data management, interoperability, and intellectual property management remain. However, the potential for new drugs and drug candidates, combined with the growing demand for combinatorial chemical methods, is expected to drive the market forward.

        • What challenges does the Chemoinformatics Industry face during its growth?

        Concerns related to data safety is a key challenge affecting the industry growth.

      • The market encompasses the application of computational methods and techniques In the fields of Drug discovery, Materials science, and Agrochemical research. This industry leverages machine learning algorithms, molecular modeling, predictive modeling, and computational chemistry applications to identify new Drug candidates, understand Structure–activity relationships, and optimize Molecular descriptors. In the Biotechnology sector, chemoinformatics is essential for Target Identification, Target Validation, and Personalized Medicine. Open-source platforms facilitate interoperability and data integration, ensuring standardized formats and protocols. In the Pharmaceutical Products sector, chemoinformatics aids Drug design, Lead targets, and Drug manufacturing. The Health Risks associated with Pharmaceutical Companies and Biotechnology Companies necessitate adherence to Intellectual Property Management and Data management.
      • The Agriculture sector benefits from chemoinformatics through Precision farming and Sustainable agrochemical development. Computational Techniques and Artificial intelligence are integral to Molecular Dynamics Simulations and Virtual Screening. Chemoinformatics software solutions cater to various industries, including the Pharmaceuticals industry, Healthcare services, and the Chemical analysis sector. User-friendly interfaces, Consultancy, and Training services are crucial to the effective implementation of these solutions. The industry's focus on Data mining, Statistical analysis, and Visualization features ensures accurate and efficient analysis of large datasets. Chemoinformatics plays a pivotal role in addressing Chronic diseases such as Alzheimer's Disease and New drugs development. Combinatorial chemical methods and Machine learning techniques enable Molecular design and Molecular interactions analysis.
      • The industry's emphasis on Data management and Interoperability ensures seamless integration and accessibility of information. In conclusion, the chemoinformatics industry is a dynamic and evolving field, driven by advancements in Computer Science, Information Science, and the increasing demand for Computational Techniques in Drug discovery, Material science applications, and Agrochemical research.

        • Exclusive Customer Landscape

        The chemoinformatics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the chemoinformatics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

        Chemoinformatics Market Share by Geography

         Customer Landscape

        Key Companies & Market Insights

        Companies are implementing various strategies, such as strategic alliances, chemoinformatics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

        Advanced Chemistry Development Inc. - The ACD Spectrus Platform in chemoinformatics facilitates the connection between analytical data and chemical context, fostering collaborative research and expediting decision-making processes. This solution empowers scientists to efficiently manage and analyze complex chemical data, enhancing overall productivity and innovation withIn the research and development sector.

        The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

        • Advanced Chemistry Development Inc.
        • Altoris
        • BioSolveIT GmbH
        • Certara Inc.
        • ChemAxon Ltd.
        • Chemical Computing Group ULC
        • Collaborative Drug Discovery Inc.
        • Danaher Corp.
        • Dassault Systemes SE
        • Daylight Chemical Information Systems Inc.
        • EPAM Systems Inc.
        • Genedata AG
        • Modgraph Consultants Ltd.
        • Molinspiration Cheminformatics
        • Molsoft LLC
        • OpenEye Scientific Software Inc.
        • Perkin Elmer Inc.
        • Scilligence Corp.
        • Tecan Trading AG

        Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

        Research Analyst Overview

        The market encompasses the application of computational methods and techniques In the fields of chemistry, computer science, and information science. This market plays a significant role in various sectors, including drug discovery, materials science, and biotechnology. Computational methods have revolutionized the way researchers approach problems In these fields. In drug discovery, chemoinformatics is used for target identification, target validation, and lead target screening. Machine learning techniques, such as regression analysis and support vector machines, are employed to analyze molecular structures, reactions, and interactions to identify potential drug candidates. The use of chemoinformatics in materials science leads to the discovery and design of new materials with improved properties.

        Computational chemistry applications, such as molecular modeling and predictive modeling, enable the optimization of molecular structures and reactions to create materials with desired characteristics. In the biotechnology sector, chemoinformatics is used for genomic and proteomic analysis, as well as drug repurposing. Open-source platforms facilitate data integration and interoperability, allowing for standardized formats and protocols. This leads to more efficient and accurate research and development. The agriculture sector also benefits from chemoinformatics through the application of computational techniques in agrochemical research. Precision farming and sustainable agrochemical development are made possible through the use of data mining and big data analytics.

        Artificial intelligence and user-friendly interfaces are increasingly being used In the chemoinformatics industry to improve the efficiency and accuracy of drug design and discovery. Consultancy and training services provide expertise and knowledge to organizations looking to implement chemoinformatics solutions. Chemoinformatics is also used In the pharmaceutical industry for drug validation, pharmaceutical product development, and intellectual property management. The healthcare cloud computing sector utilizes chemoinformatics for drug screening, virtual screening, and molecular dynamics simulations. Despite the numerous benefits of chemoinformatics, challenges remain. Interoperability and standardization of data formats and protocols are ongoing issues. Health risks associated with pharmaceutical products and the regulatory environment also impact the market.

        In conclusion, the market is a dynamic and evolving field that plays a crucial role in various industries. The application of computational methods and techniques in chemistry, computer science, and information science leads to advancements in drug discovery, materials science, and biotechnology, among others. The use of artificial intelligence and user-friendly interfaces is driving innovation and improving efficiency and accuracy. However, challenges remain, including interoperability and standardization, health risks, and regulatory issues.

        Market Scope

        Report Coverage

        Details

        Page number

        144

        Base year

        2023

        Historic period

        		 2018-2022

        Forecast period

        2024-2028

        Growth momentum & CAGR

        Accelerate at a CAGR of 13.63%

        Market growth 2024-2028

        USD 4574.1 million

        Market structure

        Fragmented

        YoY growth 2023-2024(%)

        12.14

        Key countries

        US, China, Germany, UK, and France

        Competitive landscape

        Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

        Request Free Sample

        What are the Key Data Covered in this Chemoinformatics Market Research and Growth Report?

        • CAGR of the Chemoinformatics industry during the forecast period
        • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
        • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
        • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
        • Growth of the market across North America, Europe, APAC, Middle East and Africa, and South America
        • Thorough analysis of the market’s competitive landscape and detailed information about companies
        • Comprehensive analysis of factors that will challenge the chemoinformatics market growth of industry companies

        We can help! Our analysts can customize this chemoinformatics market research report to meet your requirements.

        Get in touch

         

        Table of Contents not available.

        Research Methodology

        Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

        INFORMATION SOURCES

        Primary sources

        • Manufacturers and suppliers
        • Channel partners
        • Industry experts
        • Strategic decision makers

        Secondary sources

        • Industry journals and periodicals
        • Government data
        • Financial reports of key industry players
        • Historical data
        • Press releases

        DATA ANALYSIS

        Data Synthesis

        • Collation of data
        • Estimation of key figures
        • Analysis of derived insights

        Data Validation

        • Triangulation with data models
        • Reference against proprietary databases
        • Corroboration with industry experts

        REPORT WRITING

        Qualitative

        • Market drivers
        • Market challenges
        • Market trends
        • Five forces analysis

        Quantitative

        • Market size and forecast
        • Market segmentation
        • Geographical insights
        • Competitive landscape

        Interested in this report?

        Get your sample now to see our research methodology and insights!

        Download Now

        Frequently Asked Questions

        Chemoinformatics market growth will increase by $ 4574.1 mn during 2024-2028.

        The Chemoinformatics market is expected to grow at a CAGR of 13.63% during 2024-2028.

        Chemoinformatics market is segmented by Application( Chemical analysis, Drug discovery and validation, Virtual screening, Others)

        Advanced Chemistry Development Inc., Altoris, BioSolveIT GmbH, Certara Inc., ChemAxon Ltd., Chemical Computing Group ULC, Collaborative Drug Discovery Inc., Danaher Corp., Dassault Systemes SE, Daylight Chemical Information Systems Inc., EPAM Systems Inc., Genedata AG, Modgraph Consultants Ltd., Molinspiration Cheminformatics, Molsoft LLC, OpenEye Scientific Software Inc., Perkin Elmer Inc., Scilligence Corp., Tecan Trading AG are a few of the key vendors in the Chemoinformatics market.

        North America will register the highest growth rate of 32% among the other regions. Therefore, the Chemoinformatics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

        US, China, Germany, UK, France

        • Increasing approvals of new molecules and biosimilarsA surge in approvals of new molecular entities and biosimilars to promote the demand for safety monitoring during pre- and post-marketing phases has been observed. Drug manufacturers and developers largely rely on the successful entry and performance of their drug products in the market. Failure of their products may impact drug manufacturers adversely due to the high capital and research cost associated with drug discovery and development. Furthermore is the driving factor this market.
        • the success of a drug depends on compliance with safety standards as per regulations of the production of drugs. This mandates the requirement of drug safety monitoring before the pre- and post-market launch of any new molecular entity or biosimilar. The pharmaceutical market is experiencing a rise in the adoption of storing a large amount of chemical data among drug manufacturers. As a result is the driving factor this market.
        • the rise in the approval of new molecular entities and biosimilars and registered activities of clinical trials globally has resulted in a surge in the adoption of chemoinformatics services is the driving factor this market.
        • which is expected to drive significant market growth during the forecast period. is the driving factor this market.

        The Chemoinformatics market vendors should focus on grabbing business opportunities from the Chemical analysis segment as it accounted for the largest market share in the base year.